Literature DB >> 14662418

Trends of oral and oropharyngeal cancer survival over five decades in 3267 patients treated in a single institution.

André L Carvalho1, Mauro K Ikeda, José Magrin, Luiz P Kowalski.   

Abstract

The objective of this study was to analyze the influence of changes in the treatment on the prognosis of patients treated over 44 years in a single institution. The 5-decade trends in treatment approach and 5-year survival of 3267 patients treated between 1953 and 1997 were analyzed. An increase was observed in primary surgical treatment and its association with radiotherapy. In the 1950s, 29.1% of the patients were treated by surgery, 54.5% by radiotherapy and 16.4% by combined treatment; in the 1990s, these proportions were 39.7, 9.7 and 50.6%, respectively (P<0.001). There was a significant increase in the 5-year survival rates from 28.7% for patients treated in the 1950s to 43.2% in the 1990s (P<0.001). The changes in treatment approach for oral and oropharyngeal cancer over the last 5 decades, with an increase of surgical treatment and its combination with radiotherapy significantly improved the survival rates.

Entities:  

Mesh:

Year:  2004        PMID: 14662418     DOI: 10.1016/s1368-8375(03)00138-6

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  9 in total

Review 1.  Cancer of the oral cavity.

Authors:  Pablo H Montero; Snehal G Patel
Journal:  Surg Oncol Clin N Am       Date:  2015-04-15       Impact factor: 3.495

2.  Prognostic value of pretreatment lymphocyte-to-monocyte ratio in patients with advanced oral cavity cancer.

Authors:  Pasawat Supanimitjaroenporn; Virat Kirtsreesakul; Manupol Tangthongkum; Peesit Leelasawatsuk; Usaporn Prapaisit
Journal:  Laryngoscope Investig Otolaryngol       Date:  2022-03-30

Review 3.  [Combined modality approaches in the treatment of head and neck cancer patients].

Authors:  C Simon; P K Plinkert
Journal:  HNO       Date:  2008-06       Impact factor: 1.284

4.  Immunohistochemical expression of MMP-2 and MMP-8 in oral squamous cell carcinoma.

Authors:  Ahmed-Oluwatoyin Lawal; Akinyele-Olumuyiwa Adisa; Bamidele Kolude; Bukola-Folasade Adeyemi
Journal:  J Clin Exp Dent       Date:  2015-04-01

5.  A clinical-pathological and survival study of oral squamous cell carcinomas from a population of the North of Portugal.

Authors:  L-S Monteiro; J-B Amaral; J-R Vizcaíno; C-A Lopes; F-O Torres
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2014-03-01

6.  Gene expression patterns through oral squamous cell carcinoma development: PD-L1 expression in primary tumor and circulating tumor cells.

Authors:  Joao Paulo Oliveira-Costa; Alex Fiorini de Carvalho; da Giorgia Gobbi da Silveira; Peter Amaya; Yongqi Wu; Kyoung-Joo Jenny Park; Mabel Pinilla Gigliola; Maryam Lustberg; Marcilei Eliza Cavicchioli Buim; Elisa Napolitano Ferreira; Luiz Paulo Kowalski; Jeffrey J Chalmers; Fernando Augusto Soares; Dirce Maria Carraro; Alfredo Ribeiro-Silva
Journal:  Oncotarget       Date:  2015-08-28

7.  Survival and quality of life of patients with oral and oropharyngeal cancer at 1-year follow-up of tumor resection.

Authors:  Maria Gabriela Haye Biazevic; José Leopoldo Ferreira Antunes; Janina Togni; Fabiana Paula de Andrade; Marcos Brasilino de Carvalho; Victor Wünsch-Filho
Journal:  J Appl Oral Sci       Date:  2010 May-Jun       Impact factor: 2.698

8.  The expression profile of microRNAs in a model of 7,12-dimethyl-benz[a]anthrance-induced oral carcinogenesis in Syrian hamster.

Authors:  Tao Yu; Xiao-yi Wang; Ren-guo Gong; An Li; Sen Yang; Yu-tang Cao; Yu-ming Wen; Chang-mei Wang; Xin-zhu Yi
Journal:  J Exp Clin Cancer Res       Date:  2009-05-13

9.  Significant differences in demographic, clinical, and pathological features in relation to smoking and alcohol consumption among 1,633 head and neck cancer patients.

Authors:  Raquel Ajub Moyses; Rossana Verónica Mendoza López; Patrícia Maluf Cury; Sheila Aparecida Coelho Siqueira; Otávio Alberto Curioni; José Francisco de Gois Filho; David Livingstone Alves Figueiredo; Eloiza Helena Tajara; Pedro Michaluart
Journal:  Clinics (Sao Paulo)       Date:  2013-06       Impact factor: 2.365

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.